MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on September 10, 2004; DOI: 10.1124/mol.104.001495


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.001495v1
66/6/1635    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
Vsevolod V Gurevich
Kim A. Neve
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Macey, T. A
Right arrow Articles by Neve, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Macey, T. A
Right arrow Articles by Neve, K. A.


Received for publication April 26, 2004.
Revised September 9, 2004.
Accepted for publication September 10, 2004.

Preferential Interaction between the Dopamine D2 Receptor and Arrestin2 in Neostriatal Neurons

Tara A Macey 1, Vsevolod V Gurevich 2, Kim A. Neve 3*

1 Oregon Health & Science University 2 Vanderbilt University Medical Center 3 VA Medical Center

* Address correspondence to: E-mail: nevek{at}ohsu.edu

Abstract

Dopamine D2 receptor interactions with arrestins and arrestin-dependent internalization have been characterized using heterologously expressed D2 receptor and arrestins. The purpose of this study was to investigate D2 receptor interaction with endogenous arrestins. Arrestin2 and 3 in striatal homogenates bound to the third cytoplasmic loop of the D2 receptor, and purified arrestin2 and 3 bound to the second and third loops and C-terminus of the D2 receptor, in a GST pull-down assay. In NS20Y neuroblastoma cells expressing an enhanced green fluorescent protein-tagged D2 receptor (D2-EGFP), 2-hr D2 agonist stimulation enhanced the colocalization of D2-EGFP with endogenous arrestin2 and 3. These results suggest that the D2 receptor has the intrinsic ability to bind both non-visual arrestins. Agonist treatment of D2-EGFP NS20Y cells induced D2 receptor internalization (36-46%) that was maximal within 20 min, but that was prevented by siRNA-induced depletion of arrestin2 and 3. In neostriatal neurons, 2-hr agonist treatment selectively increased the colocalization of the endogenous D2 receptor with arrestin2, whereas receptor colocalization with arrestin3 was reduced. Agonist stimulation caused translocation of arrestin2, but not arrestin3, to the membrane in neurons, and selectively enhanced the co-immunoprecipitation of the D2 receptor and arrestin2. All three measures of receptor:arrestin interaction (colocalization, translocation, and coprecipitation) demonstrated selective agonist-induced interaction between the D2 receptor and arrestin2 in neurons.


Key words: Dopamine, Gi family, Sequestration/Internalization, GRKs, barrestins, Fluorescence techniques, Immunocytochemistry





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics